PROCTER & GAMBLE Co (PG) reported that officer Paul Gama, CEO-Health Care, received 7,727 shares of Common Stock on 2026-08-19 as a stock award under the 2025 Stock and Incentive Compensation Plan, bringing his directly held common shares to 44,227.8803.
He also acquired 7.0954 Restricted Stock Units as dividend equivalents tied to the retirement program, increasing his RSU balance to 72.6299 units, which will deliver in common shares at retirement (subject to possible deferral or contribution to a deferred compensation account). In addition, 1,173.4717 shares are held indirectly through a retirement plan trustee.
PROCTER & GAMBLE Co (PG) reported that its Chief Brand Officer, as reporting person, received equity awards and updated holdings. On 2026-08-19, the officer acquired 7,857 shares of common stock as a stock award under the 2025 Stock and Incentive Compensation Plan, bringing directly held common shares to 191,030.55, including dividend-equivalent RSUs settled in stock. On 2026-08-17, the officer was granted 276.4492 Restricted Stock Units tied to Procter & Gamble common stock under a retirement program, with delivery in shares upon retirement or deferral. The filing also reports indirect common stock holdings through the officer’s daughters, retirement plan trustees, and spouse.
PROCTER & GAMBLE Co (PG) reported insider equity activity by Chief Legal Officer & Secy Susan Street Whaley. On 2026-08-18, she sold 8,644 shares of common stock at $144.00 per share. On 2026-08-19, she received a stock award of 7,371 shares of common stock under the 2025 Stock and Incentive Compensation Plan. On 2026-08-17, she was granted 13.4479 Restricted Stock Units, representing dividend equivalents under a retirement program that will be delivered in common shares upon retirement or as otherwise deferred. An indirect retirement plan holding shows 7,187.9174 shares of common stock.
PROCTER & GAMBLE Co (PG) received a Rule 144 notice for a proposed sale of its common stock by Juliana M. Santos de Azevedo. The notice covers 2,889 shares of common stock, with an indicated value of $416,492.69, to be sold through Morgan Stanley Smith Barney LLC on the NYSE on or after August 19, 2026. The valuation is based on the average of the high and low trading prices on August 14, 2026, and the shares relate to a Performance Stock Program Award from The Procter & Gamble Company.
PROCTER & GAMBLE Co (PG) received a Rule 144 notice regarding a proposed sale of its common stock by Sundar G. Raman. The filing lists 3,772 shares of common stock held in an account at Morgan Stanley Smith Barney LLC, with an indicated value of $543,790.38 based on the average of the high and low price on August 14, 2026. A separate section describing securities to be sold under a Performance Stock Program Award references 12,439 shares of common stock with an anticipated sale date of August 19, 2026 on the NYSE. The notice is signed by an attorney-in-fact on August 18, 2026.
PROCTER & GAMBLE Co (PG) received a notice under Rule 144 indicating that Purushothaman Balaji, through Morgan Stanley Smith Barney LLC Executive Financial Services, intends to sell up to 2,450 shares of Procter & Gamble common stock on or after 08/19/2026 on the NYSE. The proposed sale has an estimated value of $353,204.25, based on the average of the high and low trading prices on August 14, 2026. The shares are related to a Performance Stock Program Award covering 6,413 shares with an acquisition date of 08/19/2026.
PROCTER & GAMBLE Co (PG) received a Rule 144 notice indicating that company officer Andre Schulten plans a sale of Procter & Gamble common stock. The notice covers a proposed sale of 6,569 shares through Morgan Stanley Smith Barney LLC, with an aggregate market value of approximately $947,019.89 based on the average of the high and low trading prices on August 14, 2026. The planned sale date listed is August 19, 2026 on the NYSE, and the shares relate to a Performance Stock Program Award.
PROCTER & GAMBLE Co (PG) received a Rule 144 notice relating to proposed sales of its common stock for the account of Susan Street Whaley. The notice involves brokerage arrangements through Morgan Stanley Smith Barney LLC and references share amounts of 2,858 and 9,874, including a Performance Stock Program Award, both tied to August 19, 2026. The price reference is based on the average of the high and low trading price on August 14, 2026, and the notice is signed by an attorney-in-fact on August 18, 2026.
PROCTER & GAMBLE Co (PG) reported a planned resale of its common stock by Marc S. Pritchard under Rule 144. A brokerage account at Morgan Stanley Smith Barney LLC lists 4,572 shares of common stock with an aggregate market value of $659,122.38, referenced to the average of the high and low trading prices on August 14, 2026, with a proposed sale date of August 19, 2026 on the NYSE. The shares relate to a Performance Stock Program Award from The Procter & Gamble Company, with an additional award amount of 10,525 shares noted in the securities-to-be-sold section.
PROCTER & GAMBLE Co (PG) received a Rule 144 notice indicating that director Jon R. Moeller plans a potential sale of 22,612 shares of common stock. The sale is arranged through Morgan Stanley Smith Barney, with an aggregate market value of $3,259,858.98, based on the average of the high and low trading prices on August 14, 2026. The securities relate to a Performance Stock Program Award, and the proposed sale date is August 19, 2026.